000 | 00824 a2200241 4500 | ||
---|---|---|---|
005 | 20250513154611.0 | ||
264 | 0 | _c19990111 | |
008 | 199901s 0 0 eng d | ||
022 | _a0889-2229 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVermund, S H | |
245 | 0 | 0 |
_aRationale for the testing and use of a partially effective HIV vaccine. _h[electronic resource] |
260 |
_bAIDS research and human retroviruses _cOct 1998 |
||
300 |
_aS321-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAIDS Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aAfrica _xepidemiology |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 |
_aHIV Infections _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRisk Factors |
773 | 0 |
_tAIDS research and human retroviruses _gvol. 14 Suppl 3 _gp. S321-3 |
|
999 |
_c9779177 _d9779177 |